In this study, we used a brca2-mutant/tp53-mutant zebrafish line to investigate the impact of brca2 mutation on cell cycle progression and ploidy outcome in normal tissue (testicular germ cells and somatic cells) and cancers. The gene discussed is BRCA2; the disease is cancer.